|
|
REVIEW
|
|
Low molecular heparins for acute therapy of venous thromboembolism
|
|
|
THERAPY FROM A CRITICAL VIEWPOINT
|
|
VADT study: again no benefit with strict glucose control in type 2 diabetes mellitus
ACCOMPLISH study: first endpoint study for starting treatment of hypertension with a combination therapy
|
|
|
IN BRIEF
|
|
Federal Joint Committee asks for reevaluation of HPV vaccination
Olanzapin (ZYPREXA): generics have to go off market
|
|
|
CURRENT ADR NETWORK REPORT
|
|
Stroke due to intravitreal bevacizumab (AVASTIN)
|
|
|
SIDE EFFECTS
|
|
Necrosis of the jaw due to alendronate (FOSAMAX, generics)
|
|
Fentanyl lollipops ACTIQ: fatal mix-up
|
|